Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs D Wave Quantum Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B), while D Wave Quantum Inc trades at $14.57 (market cap $5.54B). The key difference: D Wave Quantum Inc is far larger — about 3.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and D Wave Quantum Inc for 32 Days on average.
| NUVB | QBTS | |
|---|---|---|
Market Cap | $1.74B | $5.54B |
Volume | 9,289,619 | 16,671,452 |
Sector | Health | Technology |
52-Week High | $9.54 | $44.78 |
52-Week Low | $3.41 | $12.98 |
Typical Hold Time | 1 Days | 32 Days |
Enterprise Value | $1.33B | $5.04B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
D-Wave Quantum (QBTS) trades at $14.57, down 4.27% today, amid ongoing legal investigations and negative earnings trends. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal severe losses with a -2,001.59% net income margin despite 64.19% gross margins. Recent quarterly earnings have been mixed, missing expectations in two of the last three reported quarters.
Despite unanimous analyst buy ratings and a $34.38 price target suggesting 136% upside, significant execution risks persist. The company faces cash burn challenges with negative operating cash flow and relies heavily on financing activities. Legal investigations and competitive pressures in the quantum computing sector create substantial uncertainty for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
